Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,440.00
+46.50 (0.86%)
Sep 12, 2025, 12:30 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 644.87 billion as of September 11, 2025. Its market cap has decreased by -7.31% in one year.
Market Cap
644.87B
Enterprise Value
622.12B
Revenue
133.04B
Ranking
n/a
PE Ratio
28.23
Stock Price
5,440.00
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 644.87B, an increase of 290.35%. That is a compound annual growth rate of 15.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 644.87B | -4.27% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | 349.87B | 45.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,793.35B |
| Divi's Laboratories | 1,600.11B |
| Cipla | 1,253.31B |
| Apollo Hospitals Enterprise | 1,125.19B |
| Mankind Pharma | 1,064.67B |
| Zydus Lifesciences | 1,015.94B |
| Fortis Healthcare | 716.91B |
| Aurobindo Pharma | 606.30B |